518650947	518650947	CD	B-NP	O
|	|	NN	I-NP	O
AMC	AMC	NN	I-NP	O
|	|	NN	I-NP	O
30205575	30205575	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1940546	1940546	CD	B-NP	O
|	|	CC	I-NP	O
2/26/2005	2/26/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHF	CHF	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/27/2005	6/27/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/12/2005	6/12/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
RUBERTO	RUBERTO	NNP	B-NP	O
,	,	,	O	O
GIOVANNI	GIOVANNI	NNP	B-NP	O
281-73-02-6	281-73-02-6	CD	I-NP	O
Ra	Ra	NNP	I-NP	O
No	No	NNP	I-NP	O
Lene	Lene	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/22/05	3/22/05	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
JEAVONS	JEAVONS	NNS	B-NP	O
,	,	,	O	O
TYRONE	TYRONE	NNP	B-NP	O
JODY	JODY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
CLONIDINE	CLONIDINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
0.3	0.3	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FAMOTIDINE	FAMOTIDINE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	B-protein
NPH	NPH	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
24	24	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
8	8	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
LABETALOL	LABETALOL	NN	I-NP	O
HCL	HCL	NN	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/18/05	8/18/05	CD	B-NP	O
by	by	IN	B-PP	O
APODACE	APODACE	NN	B-NP	O
,	,	,	O	O
DAN	DAN	NNP	B-NP	O
M	M	NNP	I-NP	O
BLAKE	BLAKE	NNP	I-NP	O
LEONARDO	LEONARDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LABETALOL	LABETALOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
51131712	51131712	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ATENOLOL	ATENOLOL	NN	B-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
BRADYCARDIA	BRADYCARDIA	NNP	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
this	this	DT	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
PREDNISONE	PREDNISONE	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QAM	QAM	NN	I-NP	I-protein
SENNAGEN	SENNAGEN	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
2	2	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
BID	BID	NN	I-NP	I-DNA
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	I-DNA
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-DNA
MULTIVI	MULTIVI	NN	I-NP	I-DNA
...	...	:	O	I-DNA
-RRB-	-RRB-	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QD	QD	NN	I-NP	I-DNA
AMLODIPINE	AMLODIPINE	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/18/05	8/18/05	CD	B-NP	O
by	by	IN	B-PP	O
WILDS	WILDS	NNP	B-NP	O
,	,	,	O	O
LOWELL	LOWELL	NNP	B-NP	O
D	D	NNP	I-NP	O
EUSEBIO	EUSEBIO	NNP	I-NP	O
BYRON	BYRON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TACROLIMUS	TACROLIMUS	NNP	B-NP	O
&	&	CC	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
BESYLATE	BESYLATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
this	this	DT	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
TACROLIMUS	TACROLIMUS	NN	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q12H	Q12H	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Separate	Separate	JJ	I-NP	O
antacids	antacid	NNS	I-NP	O
by	by	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
grapefruit	grapefruit	NN	B-NP	O
juice	juice	NN	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/18/05	8/18/05	CD	B-NP	O
by	by	IN	B-PP	O
GRAVEN	GRAVEN	NNP	B-NP	O
,	,	,	O	O
MIQUEL	MIQUEL	NNP	B-NP	O
Y	Y	NNP	I-NP	O
BENNETT	BENNETT	NNP	I-NP	O
JERRY	JERRY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AMLODIPINE	AMLODIPINE	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
09130996	09130996	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TACROLIMUS	TACROLIMUS	NNP	B-NP	O
&	&	CC	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
BESYLATE	BESYLATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
this	this	DT	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
CELLCEPT	CELLCEPT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MYCOPHENOLATE	MYCOPHENOLATE	NN	I-NP	O
MOFETIL	MOFETIL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
250	250	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food	Food	NNP	I-NP	O
decreases	decrease	VBZ	B-VP	O
peak	peak	NN	B-NP	O
by	by	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
FLOMAX	FLOMAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TAMSULOSIN	TAMSULOSIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
X	X	SYM	B-NP	O
7	7	CD	I-NP	O
Days	Day	NNPS	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/12	9/12	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
4pm	4pm	NN	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Starting	Start	VBG	B-VP	O
on	on	IN	B-PP	O
5/23	5/23	CD	B-NP	O
IMDUR	IMDUR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Bamba	Bamba	NNP	I-NP	O
5/25	5/25	CD	I-NP	O
9	9	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	VBP	B-VP	O
scheduled	scheduled	JJ	B-ADJP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Warmoth	Warmoth	NNP	I-NP	O
4/5	4/5	CD	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
AM	AM	VBP	B-VP	O
scheduled	scheduled	JJ	B-ADJP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Barts	Barts	NNP	I-NP	O
8/6	8/6	CD	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
AM	AM	VBP	B-VP	O
scheduled	scheduled	JJ	B-ADJP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Saville	Saville	NNP	I-NP	O
8/23	8/23	CD	I-NP	O
9	9	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
scheduled	scheduled	JJ	B-NP	O
,	,	,	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
ATENOLOL	ATENOLOL	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHF	CHF	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	B-protein
CABG	CABG	NNP	B-NP	I-protein
'02	'02	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ESRD	ESRD	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
renal	renal	JJ	I-NP	O
txplt	txplt	NN	I-NP	O
5/9	5/9	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
end	end	NN	I-NP	O
stage	stage	NN	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hyperchol	Hyperchol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hyperpara	Hyperpara	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
hyperparathyroidism	hyperparathyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Anemia	Anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cataracts	Cataract	NNS	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
surg	surg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cataract	cataract	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NONE	NONE	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
exertional	exertional	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
IDENTIFIER/DX	IDENTIFIER/DX	NN	I-NP	O
:	:	:	O	O
77yoM	77yoM	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
htn	htn	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
ESRD	ESRD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
5/9	5/9	CD	I-NP	I-protein
,	,	,	O	O
p/w	p/w	NN	B-NP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
exertional	exertional	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
pedel	pedel	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
sided	sided	JJ	B-NP	O
reproducible	reproducible	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
occ	occ	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
across	across	IN	B-PP	O
right	right	JJ	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
to	to	TO	B-VP	O
back	back	VB	I-VP	O
,	,	,	O	O
pleuritic	pleuritic	JJ	B-ADVP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	O
1196	1196	CD	I-NP	O
,	,	,	O	O
trop	trop	NN	B-NP	O
0.1	0.1	CD	I-NP	O
.	.	.	O	O

Ddimer	Ddimer	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Admitted	Admit	VBN	B-VP	O
for	for	IN	B-PP	O
likely	likely	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
as	as	IN	B-PP	O
above	above	IN	B-ADVP	O
,	,	,	O	O
hyperparathyroidism	hyperparathyroidism	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
cataracts	cataract	NNS	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
DAILY	DAILY	NN	I-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
97.8	97.8	CD	B-NP	O
55176/64	55176/64	CD	I-NP	O
18	18	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

Gen	Gen	NN	B-NP	O
:	:	:	O	O
lying	lie	VBG	B-VP	O
flat	flat	JJ	B-ADJP	O
on	on	IN	B-PP	O
stretcher	stretcher	NN	B-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
comfortably	comfortably	RB	B-ADVP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
over	over	RB	B-ADVP	O
at	at	IN	B-PP	O
L	L	NN	B-NP	O
clavicle	clavicle	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Lungs	Lung	NNS	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
RR	RR	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
?	?	.	O	O

S4	S4	NN	B-NP	O
3/6	3/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
blowing	blow	VBG	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
axilla	axilla	NN	B-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
LLSB	LLSB	NNP	B-NP	O
,	,	,	O	O
JVP	JVP	NNP	B-NP	O
11cm	11cm	NNP	I-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
palpable	palpable	JJ	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
forearm	forearm	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
tender	tender	NN	I-NP	O
non-pitting	non-pitting	JJ	I-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
cool	cool	JJ	B-NP	O
feet	foot	NNS	I-NP	O
,	,	,	O	O
palpable	palpable	JJ	B-NP	O
DP/PT	DP/PT	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
b/l	b/l	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
DAILY	DAILY	NN	B-NP	O
EVENTS	EVENTS	NNS	I-NP	O
:	:	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
STUDIES/PROCEDURES	STUDIES/PROCEDURES	NN	B-NP	O
:	:	:	O	O
4/9	4/9	CD	B-NP	O
ECHO	ECHO	NN	I-NP	O
EF	EF	NN	I-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
MR	MR	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
TR	TR	NN	I-NP	O
8/13	8/13	CD	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
EKG/ECHO	EKG/ECHO	NN	I-NP	B-protein
changes	change	VBZ	B-VP	O
c/w	c/w	NN	B-NP	B-protein
ischemia	ischemia	NN	I-NP	I-protein
but	but	CC	O	I-protein
non-diagnostic	non-diagnostic	JJ	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
peak	peak	JJ	I-NP	I-protein
HR	HR	NN	I-NP	I-protein
64	64	CD	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
140/66	140/66	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
4/11	4/11	CD	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

vascular	vascular	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
cephalization	cephalization	NN	I-NP	O
,	,	,	O	O
formal	formal	JJ	B-NP	O
read	read	NN	I-NP	O
no	no	DT	B-NP	O
CHF	CHF	NN	I-NP	O
10/26	10/26	CD	I-NP	O
EKG	EKG	NN	I-NP	O
sinus	sinus	NN	I-NP	O
brady	brady	NN	I-NP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	O
int	int	NN	I-NP	O
,	,	,	O	O
non-spec	non-spec	JJ	B-NP	O
Twchanges	Twchange	NNS	I-NP	O
,	,	,	O	O
unchaged	unchaged	JJ	B-ADJP	O
from	from	IN	B-PP	O
9/8	9/8	CD	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
CONSULTS	CONSULTS	NNS	I-NP	O
:	:	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
exertional	exertional	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
77yoM	77yoM	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
p/w	p/w	NN	B-NP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
exertional	exertional	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
can	can	MD	B-VP	O
walk	walk	VB	I-VP	O
4-5	4-5	CD	B-NP	O
blocks	block	NNS	I-NP	O
,	,	,	O	O
over	over	IN	B-PP	O
last	last	JJ	B-NP	B-protein
couple	couple	NN	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
can	can	MD	B-VP	O
only	only	RB	I-VP	O
walk	walk	VB	I-VP	O
about	about	IN	B-NP	O
1	1	CD	I-NP	O
block	block	NN	I-NP	O
before	before	IN	B-PP	O
becoming	become	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Was	Be	VBD	B-VP	O
also	also	RB	I-VP	O
getting	get	VBG	I-VP	O
SOB	SOB	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
minimal	minimal	JJ	I-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
including	include	VBG	B-PP	O
showering	showering	NN	B-NP	O
.	.	.	O	O

Sleeps	Sleep	NNS	B-NP	O
on	on	IN	B-PP	O
one	one	CD	B-NP	O
pillow	pillow	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
.	.	.	O	O

Has	Has	NNP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
few	few	JJ	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
urination	urination	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
thirst	thirst	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
reported	report	VBN	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
diet	diet	NN	B-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
stopped	stop	VBD	B-VP	O
HCTZ	HCTZ	NN	B-NP	B-protein
but	but	CC	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
meds	med	NNS	B-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
some	some	DT	B-NP	O
dull	dull	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
over	over	IN	B-PP	O
left	left	JJ	B-NP	O
side	side	NN	I-NP	O
that	that	WDT	B-NP	O
radiates	radiate	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
band	band	NN	I-NP	O
like	like	IN	B-PP	O
fashion	fashion	NN	B-NP	O
across	across	IN	B-PP	O
his	his	PRP$	B-NP	O
stenum	stenum	NN	I-NP	O
to	to	TO	B-VP	O
back	back	VB	I-VP	O
,	,	,	O	O
3-4/10	3-4/10	CD	B-NP	O
in	in	IN	B-PP	O
intensity	intensity	NN	B-NP	O
,	,	,	O	O
not	not	RB	B-VP	O
brought	bring	VBN	I-VP	O
on	on	RP	B-PRT	O
by	by	IN	B-PP	O
activity	activity	NN	B-NP	O
,	,	,	O	O
lasts	last	NNS	B-NP	O
for	for	IN	B-PP	O
seconds	second	NNS	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
when	when	WRB	B-ADVP	O
present	present	JJ	B-NP	O
,	,	,	I-NP	O
pleuritic	pleuritic	JJ	I-NP	O
.	.	.	O	O

Reproducible	Reproducible	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
palpation	palpation	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
fallen	fall	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	B-protein
side	side	NN	I-NP	I-protein
several	several	JJ	B-NP	I-protein
weeks	week	NNS	I-NP	I-protein
earlier	earlier	RBR	B-ADVP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
dull	dull	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
quadrants	quadrant	NNS	I-NP	O
usually	usually	RB	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
bowel	bowel	NN	B-NP	O
movements	movement	NNS	I-NP	O
,	,	,	O	O
last	last	JJ	B-NP	O
BM	BM	NN	I-NP	O
yesterday	yesterday	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
n/v	n/v	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
travel	travel	NN	I-NP	O
.	.	.	O	O

March	March	NNP	B-NP	O
wt	wt	NN	I-NP	O
158lbs	158lb	NNS	I-NP	O
by	by	IN	B-PP	O
records	record	NNS	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
noticed	notice	VBN	I-VP	O
any	any	DT	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	VBZ	B-VP	O
not	not	RB	I-VP	O
having	have	VBG	I-VP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
previously	previously	RB	B-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
by	by	IN	B-PP	O
records	record	NNS	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
3/2/05	3/2/05	CD	B-NP	O
for	for	IN	B-PP	O
similar	similar	JJ	B-NP	O
atypical	atypical	JJ	I-NP	O
chest	chest	NN	I-NP	O
pains	pain	NNS	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	B-ADVP	O
a	a	DT	B-NP	O
neg	neg	NN	I-NP	O
workup	workup	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
ECHO	ECHO	NN	B-NP	O
4/9	4/9	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfn	dysfn	NN	I-NP	O
EF	EF	NN	I-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NNP	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
MR	MR	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
stress	stress	NN	B-NP	O
test	test	NN	I-NP	O
8/13	8/13	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
c/w	c/w	VBP	B-VP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
or	or	CC	I-NP	O
ECHO	ECHO	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
but	but	CC	O	O
non-diagnositic	non-diagnositic	JJ	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
peak	peak	JJ	B-NP	B-protein
HR	HR	NN	I-NP	I-protein
64	64	CD	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
140/66	140/66	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Decuir	Decuir	NNP	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	DT	B-NP	O
ACS/ischemia	ACS/ischemia	NN	I-NP	O
was	be	VBD	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
symptoms	symptom	NNS	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
CHF	CHF	NN	I-NP	O
and	and	CC	I-NP	O
MR	MR	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
ECHO	ECHO	NN	I-NP	B-protein
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
new	new	JJ	B-NP	O
AI	AI	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
apparently	apparently	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ACE	ACE	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
for	for	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
right	right	RB	B-ADVP	O
now	now	RB	I-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
why	why	WRB	B-ADVP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
w/u	w/u	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
was	be	VBD	B-VP	O
suggested	suggest	VBN	I-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
persistent	persistent	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
resolved	resolve	VBN	I-VP	O
by	by	IN	B-PP	O
these	these	DT	B-NP	O
notes	note	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	VBN	B-NP	O
97.8	97.8	CD	I-NP	O
55176/64	55176/64	CD	I-NP	O
18	18	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	O
1196	1196	CD	I-NP	O
,	,	,	O	O
trop-I	trop-I	NN	B-NP	O
0.10	0.10	CD	I-NP	O
.	.	.	O	O

d-dimer	d-dimer	NN	B-NP	O
272	272	CD	I-NP	O
.	.	.	O	O

Got	Got	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
sinus	sinus	NN	I-NP	I-protein
brady	brady	VBP	B-VP	O
no	no	DT	B-NP	O
ST/TW	ST/TW	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

D-dimer	D-dimer	NN	B-NP	O
272	272	CD	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
acute	acute	JJ	I-NP	O
cardiopulmonary	cardiopulmonary	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
PMH	PMH	NN	B-NP	O
:	:	:	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
HaA1C	HaA1C	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
7.3	7.3	CD	B-NP	O
in	in	IN	B-PP	O
9/24	9/24	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
ESRD	ESRD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
11/1	11/1	CD	I-NP	I-protein
,	,	,	O	O
hyperparathyroidism	hyperparathyroidism	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
cataracts	cataract	NNS	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
ADMISSION	ADMISSION	NN	B-NP	O
MEDs	MED	NNS	I-NP	O
:	:	:	O	O
Tacrolimus	Tacrolimus	NN	B-NP	O
2mg	2mg	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
cellcept	cellcept	VBD	B-VP	O
250	250	CD	B-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
pred	pre	VBD	B-VP	O
5mg	5mg	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
labetolol	labetolol	NN	B-NP	O
600mg	600mg	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
60mg	60mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
clonidine	clonidine	NN	B-NP	O
0.3	0.3	CD	I-NP	O
mg	mg	NN	I-NP	O
bid	bid	RB	B-ADVP	O
,	,	,	O	O
amlodipine	amlodipine	NN	B-NP	O
10mg	10mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
flomax	flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
famotidine	famotidine	NN	B-NP	O
20mg	20mg	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
81mg	81mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	O
24U	24U	NN	I-NP	O
qam	qam	NN	I-NP	O
,	,	,	O	O
16U	16U	NN	B-NP	O
qpm	qpm	NN	I-NP	O
+	+	SYM	B-NP	O
humalog	humalog	NN	I-NP	O
SS	SS	NN	I-NP	O
,	,	,	O	O
colace	colace	NN	B-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
,	,	,	O	O
MVI	MVI	NN	B-NP	O
.	.	.	O	O

hctz	hctz	NN	B-NP	O
stopped	stop	VBD	B-VP	O
10/25	10/25	CD	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
per	per	IN	B-PP	O
pt	pt	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
Per	Per	NNP	I-NP	O
records	record	VBZ	B-VP	O
atenolol	atenolol	NN	B-NP	O
-	-	HYPH	O	O
>	>	SYM	O	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
FH	FH	NN	B-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
lives	live	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
wife	wife	NN	I-NP	O
in	in	IN	B-PP	O
Mil	Mil	NNP	B-NP	O
on	on	IN	B-PP	O
1st	1st	JJ	B-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
story	story	NN	I-NP	O
complex	complex	NN	I-NP	O
,	,	,	O	O
dtr	dtr	NN	B-NP	O
lives	live	VBZ	B-VP	O
upstairs	upstairs	NN	B-NP	O
.	.	.	O	O

2-3	2-3	CD	B-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
smoking	smoking	NN	I-NP	O
hx	hx	NN	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
IVDU	IVDU	NN	I-NP	B-protein
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
ADMISSION	ADMISSION	NN	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
T	T	NN	I-NP	O
97.8	97.8	CD	B-NP	O
HR	HR	NN	I-NP	O
55	55	CD	B-NP	O
BP	BP	NN	I-NP	O
176/64	176/64	CD	B-NP	O
RR	RR	NN	I-NP	O
18	18	CD	B-NP	O
SpO2	SpO2	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Wt	Wt	NNP	B-NP	O
164	164	CD	I-NP	O
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
lying	lie	VBG	B-VP	O
flat	flat	JJ	B-ADJP	O
on	on	IN	B-PP	O
stretcher	stretcher	NN	B-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
comfortably	comfortably	RB	B-ADVP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
NC/AT	NC/AT	NN	B-NP	B-protein
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
anicteric	anicteric	NN	B-NP	O
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
MMM	MMM	NN	B-NP	O
w/o	w/o	NN	I-NP	O
exudates	exudate	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
supple	supple	NN	B-NP	O
,	,	,	O	O
NT	NT	NN	B-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
ROM	ROM	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotid	carotid	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
w/o	w/o	NN	B-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
,	,	,	O	O
murmur	murmur	NN	B-NP	O
heard	hear	VBD	B-VP	O
over	over	RB	B-ADVP	O
at	at	IN	B-PP	O
L	L	NN	B-NP	O
clavicle	clavicle	NN	I-NP	O
Lungs	Lung	NNS	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
c/w/r	c/w/r	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RR	RR	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
?	?	.	O	O

S4	S4	NN	B-NP	O
3/6	3/6	CD	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
blowing	blow	VBG	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
axilla	axilla	NN	B-NP	O
,	,	,	O	O
2/6	2/6	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
LLSB	LLSB	NNP	B-NP	O
,	,	,	O	O
JVP	JVP	NNP	B-NP	O
11cm	11cm	NNP	I-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
NT/ND	NT/ND	NN	I-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
BS	BS	NNP	B-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
Ext	Ext	NNP	B-NP	O
:	:	:	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
palpable	palpable	JJ	I-NP	O
AV	AV	NN	I-NP	O
fistula	fistula	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
forearm	forearm	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
tender	tender	NN	I-NP	O
non-pitting	non-pitting	JJ	I-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
cool	cool	JJ	B-NP	O
feet	foot	NNS	I-NP	O
,	,	,	O	O
palpable	palpable	JJ	B-NP	O
DP/PT	DP/PT	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
b/l	b/l	NN	B-NP	O
Skin	Skin	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
rashes	rashe	VBZ	B-VP	O
Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
and	and	CC	I-NP	O
O	O	NN	I-NP	B-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
CN	CN	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
through	through	IN	B-PP	O
XII	XII	CD	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Moving	Move	VBG	B-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
AND	AND	CC	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
Cr	Cr	NN	B-NP	B-protein
1.9	1.9	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
coags	coag	NNS	B-NP	O
nl	nl	NN	I-NP	O
,	,	,	O	O
LFTs	LFT	NNS	B-NP	B-protein
nl	nl	NN	I-NP	I-protein
,	,	,	O	O
TnI	TnI	NN	B-NP	O
.10	.10	CD	I-NP	O
-LRB-	-LRB-	:	O	O
CK	CK	NN	B-NP	O
251	251	CD	I-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
5.3	5.3	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
1196	1196	CD	I-NP	I-protein
d-dimer	d-dimer	NN	I-NP	I-protein
272	272	CD	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
wnl	wnl	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
Hct	Hct	NN	B-NP	O
36.9	36.9	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

4/9	4/9	CD	B-NP	O
ECHO	ECHO	NN	I-NP	O
EF	EF	NN	I-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
MR	MR	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
TR	TR	NN	I-NP	O
8/13	8/13	CD	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
EKG/ECHO	EKG/ECHO	NN	I-NP	B-protein
changes	change	VBZ	B-VP	O
c/w	c/w	NN	B-NP	B-protein
ischemia	ischemia	NN	I-NP	I-protein
but	but	CC	O	I-protein
non-diagnostic	non-diagnostic	JJ	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
peak	peak	JJ	I-NP	I-protein
HR	HR	NN	I-NP	I-protein
64	64	CD	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
140/66	140/66	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
4/11	4/11	CD	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

vascular	vascular	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
cephalization	cephalization	NN	I-NP	O
,	,	,	O	O
formal	formal	JJ	B-NP	O
read	read	NN	I-NP	O
no	no	DT	B-NP	O
CHF	CHF	NN	I-NP	O
10/26	10/26	CD	I-NP	O
EKG	EKG	NN	I-NP	O
sinus	sinus	NN	I-NP	O
brady	brady	NN	I-NP	O
at	at	IN	B-PP	O
50	50	CD	B-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
nl	nl	NN	B-NP	O
int	int	NN	I-NP	O
,	,	,	O	O
non-spec	non-spec	JJ	B-NP	O
Twchanges	Twchange	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
TWI	TWI	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
aVl	aVl	NN	B-NP	O
,	,	,	O	O
V5	V5	NN	B-NP	B-protein
,	,	,	O	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
unchaged	unchaged	JJ	B-ADJP	O
from	from	IN	B-PP	O
9/8	9/8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
77yoM	77yoM	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
htn	htn	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
2003	2003	CD	I-NP	O
,	,	,	O	O
ESRD	ESRD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
transplant	transplant	NN	I-NP	I-protein
5/9	5/9	CD	I-NP	I-protein
,	,	,	O	O
p/w	p/w	NN	B-NP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
exertional	exertional	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
sided	sided	JJ	B-NP	O
reproducible	reproducible	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
occ	occ	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
across	across	IN	B-PP	O
right	right	JJ	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
to	to	TO	B-VP	O
back	back	VB	I-VP	O
,	,	,	O	O
pleuritic	pleuritic	JJ	B-NP	O
,	,	,	I-NP	O
exam	exam	NN	I-NP	O
notable	notable	JJ	I-NP	O
for	for	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
JVP	JVP	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
not	not	RB	B-ADJP	O
obvious	obvious	JJ	I-ADJP	O
for	for	IN	B-PP	O
congestion	congestion	NN	B-NP	O
,	,	,	O	O
labs	lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
BNP	BNP	NN	B-NP	O
1196	1196	CD	I-NP	O
,	,	,	O	O
trop	trop	NN	B-NP	O
0.1	0.1	CD	I-NP	O
,	,	,	O	O
Ddimer	Ddimer	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Suspect	Suspect	NN	B-NP	O
CHF	CHF	NN	I-NP	O
as	as	IN	B-PP	O
cause	cause	NN	B-NP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-VP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Suspicion	Suspicion	NN	B-NP	O
for	for	IN	B-PP	O
ACS	ACS	NN	B-NP	O
low	low	JJ	I-NP	O
given	give	VBN	B-VP	O
previous	previous	JJ	B-NP	O
neg	neg	NN	I-NP	O
w/u	w/u	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
similar	similar	JJ	B-NP	O
atypical	atypical	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
presentation	presentation	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
also	also	RB	B-ADVP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
2/2	2/2	CD	B-NP	O
CHF	CHF	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
--	--	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
I	I	NN	B-NP	O
:	:	:	O	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
suspicion	suspicion	NN	B-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
low	low	JJ	I-NP	O
.	.	.	O	O

Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	B-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Suspect	Suspect	JJ	B-NP	O
elevated	elevated	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
2/2	2/2	CD	I-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
from	from	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
.	.	.	O	O

Not	Not	RB	O	O
on	on	IN	B-PP	O
statin	statin	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
lipid	lipid	NN	B-NP	O
panel	panel	NN	I-NP	O
in	in	IN	B-PP	O
10/25	10/25	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
LDL	LDL	NN	B-NP	B-protein
87	87	CD	I-NP	I-protein
and	and	CC	O	O
total	total	JJ	B-NP	O
chol	chol	NN	I-NP	O
166	166	CD	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
ACE	ACE	NN	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
5mg	5mg	NN	I-NP	O
.	.	.	O	O

MIBI	MIBI	LS	B-LST	O
no	no	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
goal	goal	JJ	B-NP	B-protein
dry	dry	JJ	I-NP	I-protein
weight	weight	NN	I-NP	I-protein
158	158	CD	B-NP	I-protein
lbs	lb	NNS	I-NP	I-protein
,	,	,	O	O
admission	admission	NN	B-NP	B-protein
weight	weight	NN	I-NP	I-protein
164	164	CD	B-NP	I-protein
lbs	lb	NNS	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
60mg	60mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-ADJP	O
,	,	,	O	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
60mg	60mg	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
dc	dc	NN	B-NP	O
weight	weight	NN	I-NP	O
160.5	160.5	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
send	send	VB	I-VP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
60mg	60mg	NN	B-NP	O
BID	BID	NN	I-NP	O
x	x	SYM	O	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
then	then	RB	O	O
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
60mg	60mg	VB	I-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Concern	Concern	NN	B-NP	O
that	that	IN	B-SBAR	O
worsening	worsen	VBG	B-VP	O
MR	MR	NN	B-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
constributing	constribute	VBG	I-VP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	O	O
possibly	possibly	RB	B-VP	O
flash	flash	VB	I-VP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
htn	htn	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
ECHO	ECHO	NN	B-NP	B-protein
showed	show	VBD	B-VP	I-protein
mid/mod	mid/mod	NN	B-NP	I-protein
MR	MR	NN	I-NP	I-protein
not	not	RB	B-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
4/9	4/9	CD	B-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
trace	trace	NN	I-NP	O
AI	AI	NN	I-NP	O
,	,	,	O	O
mild/mod	mild/mod	NN	B-NP	B-DNA
TR	TR	NN	I-NP	I-DNA
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
restrictive	restrictive	JJ	I-NP	O
defect	defect	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
WMA	WMA	NN	I-NP	O
,	,	,	O	O
PAP	PAP	NN	B-NP	B-protein
58	58	CD	I-NP	I-protein
+	+	SYM	I-NP	O
RAP	RAP	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
preogressive	preogressive	JJ	B-NP	O
increased	increase	VBN	B-VP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
ECHO	ECHO	NN	I-NP	O
reports	report	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
41	41	CD	B-NP	O
in	in	IN	B-PP	O
4/9	4/9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
cor	cor	NN	I-NP	O
pulmonale	pulmonale	NN	I-NP	O
from	from	IN	B-PP	O
left	left	JJ	B-NP	O
sided	sided	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

MIBI	MIBI	NNP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
ishcemia	ishcemia	NN	I-NP	O
.	.	.	O	O

Was	Wa	NNS	B-NP	B-protein
on	on	IN	B-PP	O
labetalol	labetalol	NN	B-NP	O
and	and	CC	I-NP	O
norvasc	norvasc	NN	I-NP	O
for	for	IN	B-PP	O
htn	htn	NN	B-NP	O
and	and	CC	I-NP	O
BPs	BP	NNS	I-NP	O
suboptimal	suboptimal	JJ	B-ADJP	O
in	in	IN	B-PP	O
160s	160s	CD	B-NP	O
-180	-180	CD	I-NP	O
s	s	NN	I-NP	O
,	,	,	O	O
previously	previously	RB	B-ADVP	O
on	on	IN	B-PP	O
captopril	captopril	NN	B-NP	O
37.5	37.5	CD	I-NP	O
TID	TID	NN	I-NP	O
but	but	CC	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
.	.	.	O	O

started	start	VBN	B-VP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
5mg	5mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
afterload	afterload	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
setting	set	VBG	B-VP	O
of	of	IN	B-PP	O
MR	MR	NN	B-NP	B-protein
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
f/u	f/u	VB	I-VP	O
K	K	NN	B-NP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
2	2	CD	B-NP	O
doses	dose	NNS	I-NP	O
captopril	captopril	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
25	25	CD	B-NP	O
and	and	CC	I-NP	O
37.5	37.5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
without	without	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
but	but	CC	B-PP	O
on	on	IN	B-PP	O
higher	high	JJR	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

Imdur	Imdur	NNP	B-NP	O
30mg	30mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
also	also	RB	B-ADVP	O
added	add	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
clonidine	clonidine	NN	B-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
,	,	,	O	O
sinus	sinus	NN	B-NP	O
brady	brady	NN	I-NP	O
,	,	,	O	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
RESP	RESP	NN	B-NP	O
:	:	:	O	O
satting	satte	VBG	B-VP	O
fine	fine	JJ	B-ADJP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
after	after	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
GI	GI	NN	B-NP	O
:	:	:	O	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
cont	cont	NN	B-NP	O
colace	colace	NN	I-NP	O
and	and	CC	I-NP	O
senna	senna	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
pepcid	pepcid	NN	B-NP	O
given	give	VBN	B-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
ESRD	ESRD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
transplant	transplant	NN	I-NP	O
11/1	11/1	CD	I-NP	O
.	.	.	O	O

cont	cont	JJ	B-NP	O
tacrolimus	tacrolimus	NN	I-NP	O
,	,	,	O	O
cellcept	cellcept	NN	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

Tacrolimus	Tacrolimus	NN	B-NP	O
levels	level	NNS	I-NP	O
nl	nl	NN	I-NP	B-protein
.	.	.	O	O

Followed	Follow	VBN	B-VP	O
by	by	IN	B-PP	O
renal	renal	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
team	team	NN	I-NP	O
who	who	WP	B-NP	O
agreed	agree	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
BPs	BP	NNS	B-NP	B-protein
above	above	IN	B-PP	O
.	.	.	O	O

--	--	:	O	O
HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

--	--	:	B-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
nph	nph	NN	I-NP	O
regimen	regimen	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
novolog	novolog	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
became	become	VBD	B-VP	O
hypoglycemic	hypoglycemic	JJ	B-ADJP	O
overnight	overnight	JJ	I-ADJP	O
both	both	DT	B-NP	O
nights	night	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
40s	40	NNS	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
20s	20s	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
not	not	RB	O	O
eating	eat	VBG	B-VP	O
dinner	dinner	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
both	both	CC	B-PP	O
around	around	IN	I-PP	O
3-4am	3-4am	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
says	say	VBZ	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
sometimes	sometimes	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
and	and	CC	O	O
sometimes	sometimes	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
in	in	IN	B-PP	O
100s	100	NNS	B-NP	O
.	.	.	O	O

Suspect	Suspect	VB	B-VP	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
happening	happen	VBG	I-VP	O
chronically	chronically	RB	B-NP	O
w	w	JJ	I-NP	O
/	/	SYM	I-NP	O
possible	possible	JJ	I-NP	O
rebound	rebound	NN	I-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
Will	Will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
NPH	NPH	NN	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
8U	8U	NN	I-NP	O
,	,	,	O	O
resume	resume	VBG	B-VP	O
AM	AM	NNP	B-NP	O
dose	dose	NN	I-NP	O
24U	24U	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
FEN	FEN	NN	B-NP	O
:	:	:	O	O
2L	2L	NN	B-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
sodium/chol/fat	sodium/chol/fat	NN	I-NP	O
/	/	SYM	B-VP	O
diabetic	diabetic	JJ	B-NP	O
diet	diet	NN	I-NP	O
--	--	:	O	O
PPx	PPx	NN	B-NP	B-protein
:	:	:	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
pepcid	pepcid	NN	B-NP	O
FULL	FULL	NNP	I-NP	O
CODE	CODE	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
changed	change	VBN	I-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
NPH	NPH	NN	I-NP	O
24U	24U	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	I-NP	O
8U	8U	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
your	your	PRP$	B-NP	O
overnight	overnight	JJ	I-NP	O
sugars	sugar	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
low	low	JJ	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
Lasix	Lasix	NNP	B-NP	O
60mg	60mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
go	go	VB	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
time	time	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
on	on	IN	B-PP	O
5/23	5/23	CD	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

lisinopril	lisinopril	NN	B-NP	O
and	and	CC	I-NP	O
imdur	imdur	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
added	add	VBN	I-VP	O
to	to	TO	I-VP	O
help	help	VB	I-VP	O
control	control	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
drink	drink	VB	I-VP	O
only	only	RB	B-NP	O
2L	2L	NN	I-NP	O
fluids	fluid	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
keep	keep	VB	B-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
158	158	CD	B-NP	O
lbs	lb	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
over	over	IN	B-PP	O
this	this	DT	B-NP	O
or	or	CC	I-NP	O
increases	increase	NNS	I-NP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2-3	2-3	CD	I-NP	O
lbs	lb	NNS	I-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Ruths	Ruths	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
VNA	VNA	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

monitor	monitor	NN	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

monitor	monitor	NN	B-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
CHF	CHF	NN	B-NP	B-protein
symptoms-dry	symptoms-dry	JJ	I-NP	I-protein
weight	weight	NN	I-NP	I-protein
158lbs	158lb	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
.	.	.	O	O

fingersticks	fingerstick	VBZ	B-VP	O
MD	MD	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

monitor	monitor	NN	B-NP	O
BP	BP	NN	I-NP	O
and	and	CC	I-NP	O
K	K	NN	I-NP	O
--	--	:	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
and	and	CC	O	O
imdur	imdur	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

goal	goal	JJ	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
158lbs	158lb	NNS	I-NP	O
3	3	CD	B-NP	O
.	.	.	O	O

titrate	titrate	NN	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
--	--	:	O	O
night	night	NN	B-NP	O
nph	nph	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
2/2	2/2	CD	B-NP	O
persistent	persistent	JJ	I-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
o/n	o/n	IN	B-PP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
KOGER	KOGER	NNP	B-NP	O
,	,	,	O	O
SHAD	SHAD	NNP	B-NP	O
EMMANUEL	EMMANUEL	NNP	I-NP	O
TYSON	TYSON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HT08	HT08	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
3/22/05	3/22/05	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
32	32	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

